Paper4359409
Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
Meyer TJ and 3 others. J Natl Cancer Inst, 1974. Cited by 131 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. Papers, record 4359409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4359409
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Cell Wall | Major topic |
| Disaccharides | Major topic |
| Glycolipids | Major topic |
| Immunotherapy | Major topic |
| Liver Neoplasms | Major topic |
| Mycobacterium bovis | Major topic |
| Mycolic Acids | Major topic |
| Peptides | Major topic |
| Polysaccharides | Major topic |
| Animals | |
| Guinea Pigs | |
| Immunity | |
| Male | |
| Neoplasms, Experimental | |
| Skin Tests | |
| Trehalose |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39204412 | Revitalizing Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39204412 | PubMed |
| 27265565 | Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment. | Sci Rep | 2016 | https://conductscience.org/library/papers/27265565 | PubMed |
| 26834838 | The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guérin failures for non-muscle-invasive bladder cancer. | Ther Adv Urol | 2016 | https://conductscience.org/library/papers/26834838 | PubMed |
| 18452561 | Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors. | Cancer Sci | 2008 | https://conductscience.org/library/papers/18452561 | PubMed |
| 7166915 | A patient with gastric carcinoma improved remarkably on intraperitoneal OK-432 therapy. | Jpn J Surg | 1982 | https://conductscience.org/library/papers/7166915 | PubMed |
| 6972900 | Failure of C3H mice to develop lung granuloma after intravenous injection of BCG cell wall vaccine. Demonstration of a defect in lymphoid cells. | Immunology | 1981 | https://conductscience.org/library/papers/6972900 | PubMed |
| 6389346 | Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG. | Infect Immun | 1984 | https://conductscience.org/library/papers/6389346 | PubMed |
| 3933816 | Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3933816 | PubMed |
| 3133110 | Antitumor effect of intrapleural administration of Lactobacillus casei in mice. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/3133110 | PubMed |
| 2322938 | Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships. | Cancer Immunol Immunother | 1990 | https://conductscience.org/library/papers/2322938 | PubMed |
| 1095912 | Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. | Mol Cell Biochem | 1975 | https://conductscience.org/library/papers/1095912 | PubMed |
| 826485 | Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG. | Infect Immun | 1976 | https://conductscience.org/library/papers/826485 | PubMed |
| 818016 | Adjuvant effect of cord factor, a mycobacterial lipid. | Infect Immun | 1976 | https://conductscience.org/library/papers/818016 | PubMed |
| 818013 | Analysis of the cell wall of five strains of Myocbacterium tuberculosis BCG and of an attenuated human strain, W 115. | Infect Immun | 1976 | https://conductscience.org/library/papers/818013 | PubMed |
| 804436 | Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs. | Immunology | 1975 | https://conductscience.org/library/papers/804436 | PubMed |
| 361572 | Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: comparison of BCG cell walls and cell wall skeletons. | Infect Immun | 1978 | https://conductscience.org/library/papers/361572 | PubMed |
| 203533 | Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine. | Infect Immun | 1978 | https://conductscience.org/library/papers/203533 | PubMed |
| 171670 | Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/171670 | PubMed |
| 166869 | Effect of Mycobacterium bovis and Mycobacterium tuberculosis on the take and survival of chickens with transplanted MC-29 hepatoma. | Experientia | 1975 | https://conductscience.org/library/papers/166869 | PubMed |
| 133083 | Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG). | Infect Immun | 1976 | https://conductscience.org/library/papers/133083 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4359409
GET https://conductscience.org/api/papers/v1/4359409/cited_by?page=2